Showing results (481-490 of 6,951) with videos related to
Sort By:
Pageof 696
Journal of Clinical Pharmacology|April 1, 1981
Lofexidine in the treatment of hypertension: a twice-daily versus one-daily dose comparison with 24-hour blood pressure monitoringB N Garrett, N M KaplanJournal of Clinical Pharmacology|April 1, 1981
A preliminary report on the pharmacokinetics of saccharin in man: single oral dose administrationW A Colburn, I Bekersky, H P BlumenthalJournal of Clinical Pharmacology|July 1, 1981
Hepatic microsomal induction in rat liver: heterogeneity of responseT W Kiernan, A Luisada-Opper, N H ErtelJournal of Clinical Pharmacology|July 1, 1981
Effect of obesity on gentamicin pharmacokineticsI Sketris, T Lesar, D E Zaske, et al.Journal of Clinical Pharmacology|January 1, 1981
A comparison of dopamine receptor blocking assay with plasma drug levels of haloperidol in schizophrenic patientsA A Kurland, A Nagaraju, T E Hanlon, et al.Journal of Clinical Pharmacology|June 9, 2015
Evaluation of disease-mediated therapeutic protein-drug interactions between an anti-interleukin-6 monoclonal antibody (sirukumab) and cytochrome P450 activities in a phase 1 study in patients with rheumatoid arthritis using a cocktail approachYanli Zhuang, Dick E de Vries, Zhenhua Xu, et al.Journal of Clinical Pharmacology|July 21, 2015
Assessment of pharmacokinetic drug-drug interaction between pradigastat and atazanavir or probenecidAnisha Mendonza, Imad Hanna, Dan Meyers, et al.Journal of Clinical Pharmacology|September 5, 2025
Clinical Pharmacology Characterization of the First-In-Class Oncolytic Viral Therapy T-VEC in Adults and Pediatric SubjectsXinwen Zhang, Bhavya Balu, Po-Wei Chen, et al.Journal of Clinical Pharmacology|May 27, 2015
Quantitative clinical pharmacology for size and age scaling in pediatric drug development: A systematic reviewTanay S Samant, Naveen Mangal, Viera Lukacova, et al.Journal of Clinical Pharmacology|May 27, 2015
Intranasal administration of crushed ALO-02 (extended-release oxycodone with sequestered naltrexone): A randomized, controlled abuse-potential study in nondependent recreational opioid usersBeatrice Setnik, Candace Bramson, Almasa Bass, et al.Pageof 696